Novartis AG

Prognozy (mln)




Okres 2024-12-31 2025-12-31 2026-12-31 2027-12-31 2028-12-31 2029-12-31
Przychód (średnia) 50,435.63 54,767.74 56,205.11 57,723.40 60,478.90 62,121.20
Przychód Δ r/r 0.00% 8.59% 2.62% 2.70% 4.77% 2.72%
Przychód (min) 50,035.83 54,184.43 54,629.46 55,629.97 58,285.54 59,868.28
Przychód (max) 51,175.28 55,371.87 57,563.07 60,229.90 63,105.05 64,818.66
EBITDA (średnia) 17,207.40 18,685.41 19,175.81 19,693.81 20,633.92 21,194.23
EBIT (średnia) 10,860.79 11,793.66 12,103.18 12,430.13 13,023.50 13,377.15
EBIT % 21.53% 21.53% 21.53% 21.53% 21.53% 21.53%
Zysk netto (średni) 15,341.01 18,069.40 18,793.25 19,946.13 21,588.58 23,244.42
Zysk netto % 30.42% 32.99% 33.44% 34.55% 35.70% 37.42%
EPS (średnia) 7.54 8.88 9.24 9.80 10.61 11.42
Liczba analityków (Przychody) 11 9 9 4 3 4
Liczba analityków (EPS) 6 6 6 2 3 4
symbol NVS NVS NVS NVS NVS NVS